Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

XNCR

Xencor Inc

Pharmaceutical Preparations · SIC 2834CIK 1326732Held by 3 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$126.0M
Net Income FY2025
$(92.0M)
EPS (Basic, as reported)
$-1.24
Net Margin FY2025
-73.2%
ROE FY2025
-14.5%
Total Equity
$636.0M
Shares Out
74M
Business description

Xencor Inc — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2012–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 109 → 126 +1.6% CAGR
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue1094641157123275165168110126
Research & development(52)(72)(98)(119)(170)(193)(200)(254)(228)(239)
General & administrative(13)(18)(22)(24)(30)(39)(47)(53)(61)(64)
Total operating expenses(65)(89)(120)(143)(199)(231)(247)(307)(289)(303)
Operating income23(54)(79)14(77)44(82)(139)(178)(178)
Interest expense000——00(6)(37)(32)
Interest & investment income—————15193228
Other income (expense), net249137392818(57)88
Pre-tax income25(49)(70)27(69)83(55)(120)(235)(90)
Income tax expense(1)00000(1)(6)(2)(3)
Net income24(49)(70)27(69)83(55)(126)(233)(92)
EPS — basic$0.57($1.05)($1.31)$0.48($1.21)$1.42($0.93)($2.08)($3.58)($1.24)
EPS — diluted$0.56($1.05)($1.31)$0.46($1.21)$1.37($0.93)($2.08)($3.58)($1.24)
Shares outstanding — basic (M)41475457575860616574
Shares outstanding — diluted (M)42475458576060616574

Showing the latest 10 of 14 fiscal years.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.